Safety and tolerability of pooled human immune globulins after topical ophthalmic administration in New Zealand White rabbits

Author:

Kaja Simon12,Iqbal Sana3,Pons Lopez Berta4,Molina Zaragoza Sergio4,Mun Christine56,Flavin Michael T.5,Jain Sandeep56

Affiliation:

1. Ophthalmology, Loyola University Chicago, Maywood, Illinois, USA

2. Molecular Pharmacology and Neuroscience, Loyola University Chicago, Maywood, Illinois, USA

3. Program in Molecular Pharmacology and Therapeutics, Loyola University Chicago, Maywood, Illinois, USA

4. Grifols Scientific Innovation Office, Parets del Vallès, Spain

5. Eye and Ear Infirmary, University of IL at Chicago, Chicago, Illinois, USA

6. Research and Development, Selagine, Inc, Chicago, IL, USA

Funder

Dr. John P. and Therese E. Mulcahy Endowed Professorship in Ophthalmology

Grifols

Publisher

Informa UK Limited

Reference18 articles.

1. History of Immunoglobulin Replacement

2. Polyvalent immunoglobulins: challenges and perspectives;Quinti I;Blood Transfus,2013

3. Differentiating characteristics and evaluating intravenous and subcutaneous immunoglobulin;Ness S.;Am J Manag Care,2019

4. Flebogamma® 5% DIF development: rationale for a new option in intravenous immunoglobulin therapy

5. Pathological consequences of anti-citrullinated protein antibodies in tear fluid and therapeutic potential of pooled human immune globulin-eye drops in dry eye disease

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3